{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T05:51:52Z","timestamp":1773813112384,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.jbspin.2017.05.013","type":"journal-article","created":{"date-parts":[[2017,5,18]],"date-time":"2017-05-18T19:20:05Z","timestamp":1495135205000},"page":"525-530","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis"],"prefix":"10.1016","volume":"84","author":[{"given":"Marco","family":"Sebastiani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiola","family":"Atzeni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Milazzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Quartuccio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Scir\u00e8","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni Battista","family":"Gaeta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Lapadula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orlando","family":"Armignacco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcello","family":"Tavio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignazio","family":"Olivieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierluigi","family":"Meroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Bazzichi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Grassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Mastroianni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evangelista","family":"Sagnelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Santantonio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Uberti Foppa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Puoti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loredana","family":"Sarmati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Air\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar Massimiliano","family":"Epis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossana","family":"Scrivo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Gargiulo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agostino","family":"Riva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreina","family":"Manfredi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Ciancio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianguglielmo","family":"Zehender","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria","family":"Taliani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Meroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Sollima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piercarlo","family":"Sarzi-Puttini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Galli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2017.05.013_bib0005","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.vaccine.2011.12.116","article-title":"Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity","volume":"30","author":"Ott","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jbspin.2017.05.013_bib0010","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"EASL Clinical Practice Guidelines: management of chronic hepatitis B virus infection","volume":"57","author":"European Association for the Study of the Liver","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jbspin.2017.05.013_bib0015","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jhep.2006.10.007","article-title":"Occult hepatitis B virus infection","volume":"46","author":"Raimondo","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.jbspin.2017.05.013_bib0020","doi-asserted-by":"crossref","first-page":"S156","DOI":"10.1002\/hep.22945","article-title":"Reactivation of hepatitis B","volume":"49","author":"Hoofnagle","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jbspin.2017.05.013_bib0025","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1002\/acr.20576","article-title":"Is routine viral screening useful in patients with recent-onset polyarthritis of a duration of at least 6 weeks? Results from a nationwide longitudinal prospective cohort study","volume":"63","author":"Varache","year":"2011","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jbspin.2017.05.013_bib0030","doi-asserted-by":"crossref","first-page":"e3551","DOI":"10.1097\/MD.0000000000003551","article-title":"Association of Rheumatoid Arthritis and Hepatitis B Infection: a nationwide nested case-control study from 1999 to 2009 in Taiwan","volume":"95","author":"Hsu","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.jbspin.2017.05.013_bib0035","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jbspin.2011.05.019","article-title":"Usefulness of routine hepatitis C and hepatitis B serology in the diagnosis of recent-onset arthritis. Systematic prospective screening in all patients seen by the rheumatologists of a defined area--brief report","volume":"79","author":"Ansemant","year":"2012","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2017.05.013_bib0040","series-title":"The Oxford 2011 Levels of Evidence\u201d. Oxford Centre for Evidence-Based Medicine","author":"Howick","year":"2011"},{"key":"10.1016\/j.jbspin.2017.05.013_bib0045","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13075-015-0628-z","article-title":"Safety of biologic and nonbiologic disease-modifying antirheumatic drug therapy in veterans with rheumatoid arthritis and hepatitis B virus infection: a retrospective cohort study","volume":"17","author":"Burton","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2017.05.013_bib0050","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0140-6736(80)90442-0","article-title":"Serum levels of hepatitis B surface and core antigens during immunosuppressive treatment of HBsAg-positive chronic active hepatitis","volume":"2","author":"Sagnelli","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2017.05.013_bib0055","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3899\/jrheum.100692","article-title":"Reactivation of hepatitis B virus after steroid treatment in rheumatic diseases","volume":"38","author":"Cheng","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2017.05.013_bib0060","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s10067-012-1988-2","article-title":"Prospective study of HBV reactivation risk in rheumatoid arthritis patients who received conventional disease-modifying antirheumatic drugs","volume":"31","author":"Tan","year":"2012","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jbspin.2017.05.013_bib0065","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s12072-014-9597-6","article-title":"Long-term use of methotrexate does not result in hepatitis B reactivation in rheumatologic patients","volume":"9","author":"Laohapand","year":"2015","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jbspin.2017.05.013_bib0070","doi-asserted-by":"crossref","first-page":"320","DOI":"10.12669\/pjms.312.6673","article-title":"Clinical outcomes of low-dose leflunomide for rheumatoid arthritis complicated with Hepatitis B virus carriage and safety observation","volume":"31","author":"Xu","year":"2015","journal-title":"Pak J Med Sci"},{"key":"10.1016\/j.jbspin.2017.05.013_bib0075","first-page":"60","article-title":"Assessment of sulfasalazine and hydroxichloroqine hepatotoxicity in patients with rheumatic arthritis and isolated HBS-antigen positivity","volume":"1","author":"Petrov","year":"2004","journal-title":"Lik Sprava"},{"key":"10.1016\/j.jbspin.2017.05.013_bib0080","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.2169\/internalmedicine.55.5425","article-title":"Virus reactivation following salazosulfapyridine monotherapy in a patient with rheumatoid arthritis","volume":"55","author":"Akashi","year":"2016","journal-title":"Intern Med"},{"key":"10.1016\/j.jbspin.2017.05.013_bib0085","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jbspin.2014.01.015","article-title":"Systemic diseases and biotherapies: understanding, evaluating, and preventing the risk of hepatitis B reactivation","volume":"81","author":"Lunel-Fabiani","year":"2014","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2017.05.013_bib0090","doi-asserted-by":"crossref","first-page":"926836","DOI":"10.1155\/2014\/926836","article-title":"HBV reactivation in patients treated with antitumor necrosis factor-alpha (TNF-\u03b1) agents for rheumatic and dermatologic conditions: a systematic review and meta-analysis","volume":"2014","author":"Cantini","year":"2014","journal-title":"Int J Rheumatol"},{"key":"10.1016\/j.jbspin.2017.05.013_bib0095","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/acr.20130","article-title":"Safety of tumor necrosis factor alpha blockers in hepatitis B virus occult carriers (hepatitis B surface antigen negative\/anti-hepatitis B core antigen positive) with rheumatic diseases","volume":"62","author":"Caporali","year":"2010","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jbspin.2017.05.013_bib0100","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1001\/jama.2013.281115","article-title":"FDA: increased HBV reactivation risk with ofatumumab or rituximab","volume":"310","author":"Mitka","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jbspin.2017.05.013_bib0105","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1053\/j.gastro.2014.10.038","article-title":"American Gastroenterological Association Institute technical review on prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy","volume":"148","author":"Perrillo","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jbspin.2017.05.013_bib0110","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1517\/14712598.2014.912273","article-title":"Management of patients with overt or resolved hepatitis B virus infection undergoing rituximab therapy","volume":"14","author":"Vigan\u00f2","year":"2014","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.jbspin.2017.05.013_bib0115","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jhep.2008.07.014","article-title":"Statements from the Taormina expert meeting on occult hepatitis B virus infection","volume":"49","author":"Raimondo","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jbspin.2017.05.013_bib0120","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1136\/annrheumdis-2012-202088","article-title":"Long-term safety of rituximab in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection","volume":"72","author":"Mitroulis","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2017.05.013_bib0125","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/hep.27716","article-title":"Safety of long-term biologic therapy in rheumatologic patients with a previously resolved hepatitis B viral infection","volume":"62","author":"Barone","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jbspin.2017.05.013_bib0130","first-page":"91","article-title":"Hepatitis B reactivation in a patient with rheumatoid arthritis with antibodies to hepatitis B surface antigen treated with rituximab","volume":"17","author":"Gigi","year":"2013","journal-title":"Hippokratia"},{"key":"10.1016\/j.jbspin.2017.05.013_bib0135","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3899\/jrheum.151105","article-title":"Low risk of Hepatitis B virus reactivation in HBsAg-negative\/Anti-HBc-positive carriers receiving rituximab for rheumatoid arthritis: a retrospective multicenter Italian study","volume":"43","author":"Varisco","year":"2016","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2017.05.013_bib0140","first-page":"893","article-title":"Safety profile of repeated rituximab cycles in unselected rheumatoid arthritis patients: a long-term, prospective real-life study","volume":"34","author":"Vassilopoulos","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jbspin.2017.05.013_bib0145","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40360-016-0060-2","article-title":"Reactivation of occult hepatitis B virus infection under treatment with abatacept: a case report","volume":"17","author":"Talotta","year":"2016","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1016\/j.jbspin.2017.05.013_bib0150","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1002\/acr.21654","article-title":"Safety and efficacy of abatacept in eight rheumatoid arthritis patients with chronic hepatitis B","volume":"64","author":"Kim","year":"2012","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jbspin.2017.05.013_bib0155","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/acr.22786","article-title":"Safety of abatacept in rheumatoid arthritis with serologic evidence of past or present Hepatitis B virus infection","volume":"68","author":"Padovan","year":"2016","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jbspin.2017.05.013_bib0160","doi-asserted-by":"crossref","first-page":"344","DOI":"10.4254\/wjh.v7.i3.344","article-title":"Risk of hepatitis B virus reactivation in rheumatoid arthritis patients undergoing biologic treatment: Extending perspective from old to newer drugs","volume":"7","author":"De Nard","year":"2015","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jbspin.2017.05.013_bib0165","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s15010-012-0305-y","article-title":"Transient reactivation of occult hepatitis B virus infection despite lamivudine prophylaxis in a patient treated for non-Hodgkin lymphoma","volume":"41","author":"Tonziello","year":"2013","journal-title":"Infection"},{"key":"10.1016\/j.jbspin.2017.05.013_bib0170","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jhep.2016.08.009","article-title":"The role of quantitative hepatitis B surface antigen revisited","volume":"66","author":"Cornberg","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jbspin.2017.05.013_bib0175","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/hep.27609","article-title":"Recent US Food and Drug Administration warnings on hepatitis B reactivation with immune-suppressing and anticancer drugs: just the tip of the iceberg?","volume":"61","author":"Di Bisceglie","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jbspin.2017.05.013_bib0180","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/0016-5085(87)90614-7","article-title":"Natural history of acute hepatitis B surface antigen positive hepatitis in Greek adults","volume":"92","author":"Tassopoulos","year":"1987","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jbspin.2017.05.013_bib0185","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s15010-014-0642-0","article-title":"Recommendations for the management of acute hepatitis B: position paper of the Italian Society for the Study of Infectious and Tropical Diseases (SIMIT)","volume":"42","author":"Bruno","year":"2014","journal-title":"Infection"},{"key":"10.1016\/j.jbspin.2017.05.013_bib0190","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/ard.2010.137216","article-title":"EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases","volume":"70","author":"Van Assen","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2017.05.013_bib0195","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1111\/j.1365-2036.2012.05110.x","article-title":"Comparison of the effectiveness of two protocols for vaccination (standard and double dosage) against hepatitis B virus in patients with inflammatory bowel disease","volume":"35","author":"Gisbert","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jbspin.2017.05.013_bib0200","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.vaccine.2010.05.008","article-title":"Hepatitis B vaccines: WHO position paper \u2013\u00a0recommendations","volume":"28","author":"WHO Publication","year":"2010","journal-title":"Vaccine"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X17301045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X17301045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T06:16:08Z","timestamp":1719209768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X17301045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S1297319X17301045"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2017.05.013","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2017.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Soci\u00e9t\u00e9 fran\u00e7aise de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}